HomeNWRN • SWX
add
Newron Pharmaceuticals SpA
Previous close
CHF 8.07
Day range
CHF 7.90 - CHF 8.20
Year range
CHF 4.09 - CHF 11.45
Market cap
153.68M CHF
Avg Volume
100.15K
P/E ratio
-
Dividend yield
-
Primary exchange
SWX
Market news
Financials
Income Statement
Revenue
Net income
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 1.78M | 9.16% |
Operating expense | 5.44M | 7.64% |
Net income | -4.64M | -4.71% |
Net profit margin | -260.29 | 4.08% |
Earnings per share | — | — |
EBITDA | -3.64M | -6.72% |
Effective tax rate | -0.14% | — |
Balance Sheet
Total assets
Total liabilities
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 12.60M | -44.68% |
Total assets | 25.87M | -30.46% |
Total liabilities | 55.77M | 8.88% |
Total equity | -29.91M | — |
Shares outstanding | 17.85M | — |
Price to book | -4.80 | — |
Return on assets | -35.39% | — |
Return on capital | -49.46% | — |
Cash Flow
Net change in cash
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -4.64M | -4.71% |
Cash from operations | -2.27M | 16.94% |
Cash from investing | 1.63M | 3,257.73% |
Cash from financing | -47.50K | -1.06% |
Net change in cash | -687.50K | 74.81% |
Free cash flow | -2.84M | -6.46% |
About
CEO
Founded
1999
Website
Employees
22